Broadwood Partners, L.p. bought $11M of STAA
owner at STAAR SURGICAL CO. 663,761 shares at an average of $16.99, traded Feb 27, 2025, filed Mar 3, 2025.
Score components
- +12Role10% owner
- +25Trade size$11.3M at market
- +3Relative to holdingsHoldings up 6%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying4 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +6.9%, 3m +1.3%, 6m +66.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000919574-25-001761, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2025 | POpen-market purchase Common Stock | +114,713 | $16.44 | $1.9M | 11,404,150 | Mar 3, 2025 |
| Feb 27, 2025 | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 11,404,150 | Mar 3, 2025 |
| Feb 27, 2025 | POpen-market purchase Common Stock | +144,603 | $17.52 | $2.5M | 11,548,753 | Mar 3, 2025 |
| Feb 27, 2025 | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 11,548,753 | Mar 3, 2025 |
| Feb 28, 2025 | POpen-market purchase Common Stock | +153,142 | $17.45 | $2.7M | 11,701,895 | Mar 3, 2025 |
| Feb 28, 2025 | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 11,701,895 | Mar 3, 2025 |
| Feb 28, 2025 | POpen-market purchase Common Stock | +1,800 | $17.99 | $32k | 11,703,695 | Mar 3, 2025 |
| Feb 28, 2025 | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 11,703,695 | Mar 3, 2025 |
| Mar 3, 2025 | POpen-market purchase Common Stock | +230,529 | $16.57 | $3.8M | 11,934,224 | Mar 3, 2025 |
| Mar 3, 2025 | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 11,934,224 | Mar 3, 2025 |
| Mar 3, 2025 | POpen-market purchase Common Stock | +18,974 | $17.43 | $331k | 11,953,198 | Mar 3, 2025 |
| Mar 3, 2025 | POpen-market purchase Common Stockindirect: Footnote | +0 | $0.00 | $0 | 11,953,198 | Mar 3, 2025 |
Related signals
Other insiders at STAAR SURGICAL CO and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 53Moderate | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. director, owner | $12M 670,213 shares | +4% | |
| 30Weak | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $606k 27,485 shares | +0% | |
| 41Moderate | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $8.8M 406,653 shares | +3% | |
| 35Weak | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $41M 1,500,000 shares | +11% | |
| 55Moderate | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $2.9M 187,227 shares | +1% | |
| 48Moderate | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $14M 845,220 shares | +7% | |
| 39Weak | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $941k 53,969 shares | +0% | |
| 40Moderate | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $2.0M 113,384 shares | +1% | |
| 45Moderate | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $2.4M 136,696 shares | +1% | |
| 45Moderate | STAAbuy STAAR SURGICAL CO | Broadwood Partners, L.p. owner | $3.6M 201,844 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.